The Global Balance Of Power: Strategic Coordination And Diverging Interests Between The United States And China
Jurnal Cendekia Hukum Indonesia · 2025
DOI: 10.71417/jchi.v1i2.22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Cendekia Hukum Indonesia, 2025. Verfasst von Gusti Luthfi Fahrezi. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
The purpose of this study is to analyze the pattern of coordination and differences of interest between the US and China, using a qualitative approach through a literature study. The methods used include content analysis of reputable academic sources such as Scopus-indexed international journals, policy reports from think tanks, as well as secondary data from international organizations. The study builds on five main literature frameworks: realism, strategic coordination, regional conflicts, technological competition, and multilateral diplomacy. The results of the analysis show that although there are several areas of cooperation between the two countries, ideological differences and geopolitical goals remain the main obstacles. This study makes a theoretical and practical contribution to the development of the study of international relations, especially in formulating diplomatic strategies that are adaptive to the dynamics of global multipolarism.
Zitieren
APA
Fahrezi, G. L. (2025). The Global Balance Of Power: Strategic Coordination And Diverging Interests Between The United States And China. Jurnal Cendekia Hukum Indonesia. https://doi.org/10.71417/jchi.v1i2.22
Vancouver
Fahrezi GL. The Global Balance Of Power: Strategic Coordination And Diverging Interests Between The United States And China. Jurnal Cendekia Hukum Indonesia. 2025. doi:10.71417/jchi.v1i2.22
BibTeX
@article{Fahrezi2025,
author = {Fahrezi, Gusti Luthfi},
title = {The Global Balance Of Power: Strategic Coordination And Diverging Interests Between The United States And China},
journal = {Jurnal Cendekia Hukum Indonesia},
year = {2025},
doi = {10.71417/jchi.v1i2.22}
}
EUVIMED